Why You Should Never Short Biotech Stocks. The $CAPR Short Squeeze Explained + $PLRZ. #english $XBI

In this video I break down exactly how to trade clinical-stage biotech penny stocks like IXHL using a disciplined, repeatable strategy. These types of stocks move on catalysts, not hype, and timing your entries and exits is everything. I walk through why buying near the bottom matters, how to identify when a company is giving you real catalysts, and how to prepare yourself before the move happens. IXHL has already told investors what’s coming next: an end-of-Phase-2 meeting update with FDA notes